Atrovent and Paraplatin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent (ipratropium bromide) and Paraplatin (carboplatin). Common drug interactions include peripheral motor neuropathy among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Atrovent and Paraplatin. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 33,210 Atrovent users. Check the latest studies of Atrovent.

What is Paraplatin?

Paraplatin has active ingredients of carboplatin. eHealthMe is studying from 12,392 Paraplatin users. Check the latest studies of Paraplatin.



On Jul, 22, 2026

18 people who take Atrovent and Paraplatin together, and have interactions are studied.

Atrovent and Paraplatin drug interactions.

What are the common drug interactions of Atrovent and Paraplatin, by gender? *:

female:

  1. Peripheral motor neuropathy (muscles in the body become progressively weaker over months to years)
  2. Peripheral sensory neuropathy (damage to one or more of your peripheral nerves)
  3. Psychological trauma
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  6. Vulvovaginal mycotic infection (vulvovaginal fungal infection)
  7. White blood cell count decreased
  8. Constipation
  9. Fatigue (feeling of tiredness)
  10. Hypersensitivity

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Pyrexia (fever)
  3. Non-small cell lung cancer (type of epithelial lung cancer)
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Abdominal distension
  6. Abdominal pain
  7. Adrenomegaly (enlarged adrenal glands)
  8. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  9. Arthralgia (joint pain)
  10. Asthenia (weakness)

What are the common drug interactions of Atrovent and Paraplatin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Parosmia (distortion of the sense of smell, as in smelling odours that are not present)
  2. Rash
  3. Upper respiratory tract infection
  4. Vision blurred
  5. Arthralgia (joint pain)
  6. Constipation
  7. Diarrhoea
  8. Dizziness
  9. Dry eye (lack of adequate tears)
  10. Dysgeusia (disorder of the sense of taste)

40-49:

  1. Alopecia (absence of hair from areas of the body)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Psychological trauma

50-59:

  1. Asthenia (weakness)
  2. Blood creatinine increased
  3. Cachexia (loss of weight)
  4. Hypotonia (low muscle tone)
  5. Multi-organ failure (multisystem organ failure)
  6. Pyrexia (fever)
  7. Septicaemia escherichial (bacterial blood infection)

60+:

  1. Dehydration (dryness resulting from the removal of water)
  2. Leukopenia (less number of white blood cells in blood)
  3. Malignant neoplasm progression (cancer tumour came back)
  4. Nausea (feeling of having an urge to vomit)
  5. Non-small cell lung cancer (type of epithelial lung cancer)
  6. Pyrexia (fever)
  7. Abdominal distension
  8. Abdominal pain
  9. Adrenomegaly (enlarged adrenal glands)
  10. Ageusia (loss of taste functions of the tongue)

What are the existing conditions these people have? *

  1. Joint Pain: 7 people, 38.89%
  2. Breast Cancer: 6 people, 33.33%
  3. Headache (pain in head): 6 people, 33.33%
  4. Constipation: 4 people, 22.22%
  5. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 3 people, 16.67%
  6. Lung Cancer - Non-Small Cell (lung cancer): 3 people, 16.67%
  7. Upper Respiratory Tract Infection: 1 person, 5.56%
  8. Diarrhea: 1 person, 5.56%
  9. Breast Cancer Female: 1 person, 5.56%
  10. Cough: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Paraplatin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Atrovent and Paraplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Paraplatin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Paraplatin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and carboplatin (the active ingredients of Atrovent and Paraplatin, respectively), and Atrovent and Paraplatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: